Virginia facility – Talk Bio

Actionable Insights Powered by AI

AstraZeneca Onshores Rare Disease Portfolio as Part of $50B US Investment Pledge

6 hours ago talkbio0Tagged AstraZeneca, expansion, Infrequent, Investments, Maryland (geographic location), onshoring, pledge, portfolio, R&D, U.S., Virginia facility

AstraZeneca; rare disease portfolio; onshoring; US investment; biomanufacturing; $50 billion pledge; Virginia facility; Maryland investment; R&D expansion